Cargando…

The cost-saving switch from inhaled corticosteroid-containing treatments to dual bronchodilation: a two-country projection of epidemiological and economic burden in chronic obstructive pulmonary disease

PURPOSE: The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2018 recommendations support maintenance treatment with long-acting bronchodilators in most symptomatic patients with chronic obstructive pulmonary disease (COPD). While restricting the overuse of inhaled corticosteroids (ICS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Souliotis, Kyriakos, Silva Miguel, Luís, Hillas, Georgios, Borges, Margarida, Papageorgiou, Giannis, Viana, Diogo, Malhadeiro, Joao, Soulard, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7288795/ https://www.ncbi.nlm.nih.gov/pubmed/32519591 http://dx.doi.org/10.1177/1753466620926802

Ejemplares similares

Act early, save lives: managing COVID-19 in Greece
por: Gountas, Ilias, et al.
Publicado: (2020)

The role of inhaled and/or nasal corticosteroids on the bronchodilator response
por: Lee, Ju Kyung, et al.
Publicado: (2010)

Effect of allergic phenotype on treatment response to inhaled bronchodilators with or without inhaled corticosteroids in patients with COPD
por: Cheng, Shih-Lung, et al.
Publicado: (2017)

Systematic Review of Inhaled Bronchodilator and Corticosteroid Therapies in Infants with Bronchopulmonary Dysplasia: Implications and Future Directions
por: Clouse, Brian J., et al.
Publicado: (2016)

Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD
por: Bishwakarma, Raju, et al.
Publicado: (2017)

Replacing nebulizers by MDI-spacers for bronchodilator and inhaled corticosteroid administration: Impact on the utilization of hospital resources
por: Alhaider, S.A., et al.
Publicado: (2014)

Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)

Dual Bronchodilator in the Era of Triple Therapy
por: Papaioannou, Andriana I, et al.
Publicado: (2020)

Pembrolizumab-associated bronchiolitis in an elderly lung cancer patient required the treatment with an inhaled corticosteroid, erythromycin and bronchodilators
por: Yamaya, Takafumi, et al.
Publicado: (2019)

A Pooled Analysis of Mortality in Patients with COPD Receiving Dual Bronchodilation with and without Additional Inhaled Corticosteroid
por: Miravitlles, Marc, et al.
Publicado: (2022)

Cardiovascular morbidity and the use of inhaled bronchodilators
por: Macie, Christine, et al.
Publicado: (2008)

Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations
por: Calverley, Peter M, et al.
Publicado: (2016)

The direct and indirect costs of managing chronic obstructive pulmonary disease in Greece
por: Souliotis, Kyriakos, et al.
Publicado: (2017)

Reducing carbon footprint by switching to reusable soft-mist inhalers
por: Janson, Christer, et al.
Publicado: (2023)

Inhaled Bronchodilator Use for Infants with Bronchopulmonary Dysplasia
por: Slaughter, Jonathan L, et al.
Publicado: (2014)

Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis
por: DiSantostefano, Rachael L, et al.
Publicado: (2013)

Impact of long-term treatment with inhaled corticosteroids and bronchodilators on lung function in a patient with post-infectious bronchiolitis obliterans
por: Calabrese, Cecilia, et al.
Publicado: (2016)

Direct and Indirect Costs of Asthma Management in Greece: An Expert Panel Approach
por: Souliotis, Kyriakos, et al.
Publicado: (2017)

Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids
por: Asche, Carl Victor, et al.
Publicado: (2012)

Bronchodilator delivery with metered-dose inhaler during mechanical ventilation
por: Georgopoulos, Dimitris, et al.
Publicado: (2000)

Inhaled bronchodilator exposure in the management of bronchopulmonary dysplasia in hospitalized infants
por: Euteneuer, Joshua C., et al.
Publicado: (2020)

Bronchodilators, Antibiotics, and Oral Corticosteroids Use in Primary Care for Children With Cough
por: Krishnan, Sankaran, et al.
Publicado: (2019)

Inhaled Corticosteroids
por: Barnes, Peter J.
Publicado: (2010)

Risk of Pneumonia with Inhaled Corticosteroid versus Long-Acting Bronchodilator Regimens in Chronic Obstructive Pulmonary Disease: A New-User Cohort Study
por: DiSantostefano, Rachael L., et al.
Publicado: (2014)

Triple Therapy Versus Dual Bronchodilation and Inhaled Corticosteroids/Long-Acting β-Agonists in COPD: Accumulating Evidence from Network Meta-Analyses
por: Cazzola, Mario, et al.
Publicado: (2019)

Translational model to predict pulmonary pharmacokinetics and efficacy in man for inhaled bronchodilators
por: Hendrickx, Ramon, et al.
Publicado: (2017)

Uncovering the beneficial effects of inhaled bronchodilator in COPD: beyond forced spirometry
por: Neder, José Alberto, et al.
Publicado: (2019)

Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
por: Thomas, Mike, et al.
Publicado: (2009)

COVID-19, Asthma, and Inhaled Corticosteroids: Another Beneficial Effect of Inhaled Corticosteroids?
por: Maes, Tania, et al.
Publicado: (2020)

Responses of FEV(6), FVC, and FET to inhaled bronchodilator in the adult general population
por: Kainu, Annette, et al.
Publicado: (2009)

Inhaled bronchodilators and acute myocardial infarction: a nested case-control study
por: Lee, Chang-Hoon, et al.
Publicado: (2017)

Pulmonary PET imaging confirms preferential lung target occupancy of an inhaled bronchodilator
por: Schou, Magnus, et al.
Publicado: (2019)

Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities
por: Corrao, Salvatore, et al.
Publicado: (2017)

Depression Levels Influence the Rate of Asthma Exacerbations in Females
por: Anastasia, Papaporfyriou, et al.
Publicado: (2021)

The future of bronchodilation: looking for new classes of bronchodilators
por: Cazzola, Mario, et al.
Publicado: (2019)

Inhaled Corticosteroids and Bone Health
por: Chee, Carolyn, et al.
Publicado: (2014)

Inhaled Corticosteroids and COVID-19
por: Lipworth, Brian, et al.
Publicado: (2020)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Before and beyond Inhaled Corticosteroids
por: Vazquez Guillamet, Rodrigo
Publicado: (2020)

"Show me the money": a fair criticism of economic studies on inhaled bronchodilators for COPD
por: Kostikas, Konstantinos, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_9r5lu72ns4ht2fommgp9mgkmb1